Edition:
India

Danaher Corp (DHR.N)

DHR.N on New York Stock Exchange

128.07USD
18 Mar 2019
Change (% chg)

$-0.62 (-0.48%)
Prev Close
$128.69
Open
$128.81
Day's High
$129.00
Day's Low
$127.34
Volume
855,948
Avg. Vol
813,874
52-wk High
$129.41
52-wk Low
$94.62

Chart for

About

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins,... (more)

Overall

Beta: 1.01
Market Cap(Mil.): $60,875.68
Shares Outstanding(Mil.): 694.69
Dividend: 0.14
Yield (%): 0.64

Financials

GE inks $21 billion biopharma sale to Danaher in U-turn under Culp

General Electric said on Monday it would sell its biopharma business to Danaher Corp for $21.4 billion in the biggest strategy reversal since Lawrence Culp took over as the industrial conglomerate's chief executive in September. | Video

26 Feb 2019

GE inks $21 billion biopharma sale to Danaher in U-turn under Culp

General Electric said on Monday it would sell its biopharma business to Danaher Corp for $21.4 billion in the biggest strategy reversal since Lawrence Culp took over as the industrial conglomerate's chief executive in September. | Video

26 Feb 2019

UPDATE 5-GE inks $21 bln biopharma sale to Danaher in U-turn under Culp

* Danaher gains as deal boosts capability into drug development market

26 Feb 2019

GE debt rallies, bond insurance price drops on Danaher deal

General Electric Co bonds rallied broadly on Monday after the company struck a deal to sell its biopharma business to Danaher Corp for $21.4 billion and said it would use cash from the deal to ease its massive debt burden.

26 Feb 2019

GRAPHIC-GE debt rallies, bond insurance price drops on Danaher deal

Feb 25 General Electric Co bonds rallied broadly on Monday after the company struck a deal to sell its biopharma business to Danaher Corp for $21.4 billion and said it would use cash from the deal to ease its massive debt burden.

26 Feb 2019

Danaher to IPO dental unit after $21.4 bln deal to buy GE's biopharma business

Feb 25 Medical equipment maker Danaher Corp said it was considering an initial public offering for its dental business, citing the size of its $21.4 billion purchase of General Electric Co's biopharma business.

25 Feb 2019

GE sells biopharma drug business to Danaher for $21.4 bln

Feb 25 General Electric Co said on Monday it would sell its biopharma business to Danaher Corp for $21.4 billion, as the U.S. industrial conglomerate sheds non-core businesses to focus on its industrial unit.

25 Feb 2019

France's Ingenico targeted by Natixis, Edenred in payments deal flurry

PARIS/LONDON Ingenico is being pursued by business services company Edenred and corporate banking group Natixis as consolidation in the payments field heats up.

11 Oct 2018

UPDATE 2-S&P downgrades GE's credit rating, Moody's, Fitch put it on review

Oct 2 Ratings agency Standard & Poor's cut General Electric Co's credit rating on Tuesday, a day after the conglomerate announced a $23 billion charge related to its power business and ousted its chief executive officer.

03 Oct 2018

Earnings vs. Estimates